-
EP2187946
European procedure
- EP About this file
- EP Legal status
- EP Federated register
- EP Event history
- EP Citations
- EP Patent family
- EP All documents
Extract from the Register of European Patents
EP About this file: EP2187946
| EP2187946 - USE OF GALANIN (1-13) -SPANTIDE I FOR TREATING MYCOBACTERIUM TUBERCULOSIS INFECTIONS [Right-click to bookmark this link] | |||
| Former [2010/21] | USE OF A PEPTIDE AS A THERAPEUTIC AGENT | ||
| [2011/31] | Status | The application is deemed to be withdrawn Status updated on 06.07.2012 Database last updated on 02.11.2024 | Most recent event Tooltip | 06.07.2012 | Application deemed to be withdrawn | published on 08.08.2012 [2012/32] | Applicant(s) | For all designated states Mondobiotech Laboratories AG Herrengasse 21 9490 Vaduz / LI | [2010/21] | Inventor(s) | 01 /
BEVEC, Dorian Kriegerstrasse 62 82110 Germering / DE | 02 /
CAVALLI, Fabio Via Pasquée 23 6925 Gentilino / CH | 03 /
CAVALLI, Vera Via Pasquée, 23 6925 Gentilino / CH | 04 /
BACHER, Gerald Masurenweg 5 82110 Germering / DE | [2010/21] | Representative(s) | Arth, Hans-Lothar ABK Patent Attorneys Jasminweg 9 14052 Berlin / DE | [N/P] |
| Former [2010/21] | Arth, Hans-Lothar ABK Patent Attorneys Jasminweg 9 14052 Berlin / DE | Application number, filing date | 08874950.2 | 09.09.2008 | [2010/21] | WO2008EP07679 | Filing language | EN | Procedural language | EN | Publication | Type: | A1 Application with search report | No.: | WO2010028673 | Date: | 18.03.2010 | Language: | EN | [2010/11] | Type: | A1 Application with search report | No.: | EP2187946 | Date: | 26.05.2010 | Language: | EN | The application published by WIPO in one of the EPO official languages on 18.03.2010 takes the place of the publication of the European patent application. | [2010/21] | Search report(s) | International search report - published on: | EP | 18.03.2010 | Classification | IPC: | A61K38/22, A61P31/06, A61P31/20, A61P3/00, A61P9/00, A61P11/00, A61P25/28, A61P31/00, A61P35/00, A61P37/00 | [2010/21] | CPC: |
A61K38/046 (EP,US);
A61K38/17 (KR);
A61K47/50 (KR);
A61P11/00 (EP);
A61P25/28 (EP);
A61P29/00 (EP);
A61P3/00 (EP);
A61P31/00 (EP);
A61P31/04 (EP);
A61P31/06 (EP);
A61P31/20 (EP);
A61P35/00 (EP);
A61P37/00 (EP);
A61P37/06 (EP);
A61P9/00 (EP);
C07K14/47 (KR);
C07K14/575 (EP,US);
A61K38/00 (EP,US);
Y02A50/30 (EP,US)
(-)
| Designated contracting states | AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HR, HU, IE, IS, IT, LI, LT, LU, LV, MC, MT, NL, NO, PL, PT, RO, SE, SI, SK, TR [2010/21] | Title | German: | VERWENDUNG VON GALANIN (1-13) -SPANTIDE I ZUR BEHANDLUNG VON MYCOBACTERIUM TUBERCULOSIS INFEKTIONEN | [2011/31] | English: | USE OF GALANIN (1-13) -SPANTIDE I FOR TREATING MYCOBACTERIUM TUBERCULOSIS INFECTIONS | [2011/31] | French: | UTILISATION DE GALANIN (1-13) -SPANTIDE I POUT LE TRAITEMENT D'INFECTIONS CAUSÉES PAR MYCOBACTERIUM TUBERCULOSIS | [2011/31] |
| Former [2010/21] | VERWENDUNG EINES PEPTIDS ALS THERAPEUTISCHES MITTEL | ||
| Former [2010/21] | USE OF A PEPTIDE AS A THERAPEUTIC AGENT | ||
| Former [2010/21] | UTILISATION D UN PEPTIDE EN TANT QU' AGENT THÉRAPEUTIQUE | Entry into regional phase | 05.03.2010 | National basic fee paid | 05.03.2010 | Designation fee(s) paid | 05.03.2010 | Examination fee paid | Examination procedure | 05.03.2010 | Amendment by applicant (claims and/or description) | 05.03.2010 | Examination requested [2010/21] | 14.10.2010 | Despatch of a communication from the examining division (Time limit: M06) | 23.02.2011 | Reply to a communication from the examining division | 10.10.2011 | Communication of intention to grant the patent | 21.02.2012 | Application deemed to be withdrawn, date of legal effect [2012/32] | 26.03.2012 | Despatch of communication that the application is deemed to be withdrawn, reason: fee for grant / fee for printing not paid in time [2012/32] | Divisional application(s) | The date of the Examining Division's first communication in respect of the earliest application for which a communication has been issued is 14.10.2010 | Fees paid | Renewal fee | 21.08.2010 | Renewal fee patent year 03 | Penalty fee | Additional fee for renewal fee | 30.09.2011 | 04 M06 Not yet paid |
| Opt-out from the exclusive Tooltip competence of the Unified Patent Court | See the Register of the Unified Patent Court for opt-out data | ||
| Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court. | Cited in | International search | [X]US2003129702 (SMITH KELLI E [US], et al) [X] 1-12 * [0325], [0330], [0354], [0366], * * tables 1-3,6,7 *; | [Y]WO9803059 (UNIV BRISTOL [GB], et al) [Y] 1-12 * claims 1-32 * * page 2, paragraph 5 - page 4, paragraph 4 *; | [X] - WANG S ET AL, "GALANIN RECEPTORS AND THEIR THERAPEUTIC POTENTIAL", EMERGING DRUGS, ASHLEY PUBLICATIONS, LONDON, GB, (20000101), vol. 5, no. 4, ISSN 1361-9195, pages 414 - 440, XP009024289 [X] 1-12 * the whole document * | [X] - XU X J ET AL, "New high affinity peptide antagonists to the spinal galanin receptor.", BRITISH JOURNAL OF PHARMACOLOGY OCT 1995, (199510), vol. 116, no. 3, ISSN 0007-1188, pages 2076 - 2080, XP002521675 [X] 1-12 * abstract * *Discussion* | [Y] - CRAWLEY J N ET AL, "Galanin receptor antagonists M40 and C7 block galanin-induced feeding", BRAIN RESEARCH, ELSEVIER, AMSTERDAM, NL, vol. 600, no. 2, ISSN 0006-8993, (19930115), pages 268 - 272, (19930115), XP024284767 [Y] 1-12 * abstract * *Discussion* DOI: http://dx.doi.org/10.1016/0006-8993(93)91382-3 | by applicant | WO03043429 | US5962062 | WO0030461 | EP0527283 | EP0832565 |